Trial Profile
Non-Interventional Study With Aricept Evess In Patients Diagnosed With Mild And Moderate Alzheimer's Disease Or Vascular Dementia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2015
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease; Vascular dementia
- Focus Therapeutic Use
- Sponsors Pfizer
- 15 Apr 2010 Actual patient number (370) added as reported by ClinicalTrials.gov.
- 15 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jan 2010 Planned end date changed from 1 Feb 2010 to 1 Mar 2010 as reported by ClinicalTrials.gov.